Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients with Advanced Non-Small Cell Lung Cancer: Results from a Phase 2 Pivotal Study
ANNALS OF ONCOLOGY(2023)
Key words
IBI351,GFH925,NSCLC,KRAS G12C,Chinese patients,Pivotal study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined